2510-3636

European Journal of Hybrid Imaging

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 58 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact58 DOIs
2

Attach ORCID iDs across 43 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact43 DOIs
3

Deposit reference lists for 4 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact4 DOIs

DOIs for this ISSN

Showing the top 5 of 180 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 PET/MRI: a frontier in era of complementary hybrid imaging (10.1186/s41824-018-0030-6)
Abstract ORCID
90.65 64
2 The clinical value of xSPECT/CT Bone versus SPECT/CT. A pros… (10.1186/s41824-017-0024-9)
Abstract ORCID
78.41 36
3 18F- FDG PET/CT joint assessment of early therapeutic respon… (10.1186/s41824-017-0022-y)
Abstract ORCID
73.86 29
4 Trends in oncologic hybrid imaging (10.1186/s41824-017-0019-6)
Abstract ORCID
73.12 28
5 68Ga-PSMA and 11C-Choline comparison using a tri-modality PE… (10.1186/s41824-018-0027-1)
Abstract ORCID
69.01 23
6 Myocardial blood flow and myocardial flow reserve values in… (10.1186/s41824-018-0029-z)
Abstract ORCID
69.01 23
7 Cardiac PET/MRI—an update (10.1186/s41824-018-0050-2)
Abstract ORCID
62.76 17
8 Does quantification have a role to play in the future of bon… (10.1186/s41824-019-0054-6)
Abstract ORCID
62.76 17
9 Somatostatin receptor based hybrid imaging in sarcoidosis (10.1186/s41824-017-0014-y)
Abstract ORCID
55.70 12
10 Interpreting 123I–ioflupane dopamine transporter scans using… (10.1186/s41824-018-0028-0)
Abstract ORCID
55.70 12
11 Targeted 11C–choline PET-CT/TRUS software fusion-guided pros… (10.1186/s41824-017-0011-1)
Abstract ORCID
53.96 11
12 Low dose radiation 18F–fluoride PET/CT in the assessment of… (10.1186/s41824-018-0025-3)
Abstract ORCID
47.71 8
13 Skeletal standardized uptake values obtained by quantitative… (10.1186/s41824-017-0006-y)
Abstract
47.30 77
14 EANM procedural guidelines for myocardial perfusion scintigr… (10.1186/s41824-019-0058-2)
Abstract
45.49 65
15 Tumor heterogeneity measurement using [18F] FDG PET/CT shows… (10.1186/s41824-018-0043-1)
Abstract ORCID
45.15 7
16 Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloi… (10.1186/s41824-018-0035-1)
Abstract
42.90 51
17 Perfusion CT and PET with 18F–FDG and 18F–FCh in the complex… (10.1186/s41824-017-0018-7)
Abstract ORCID
42.25 6
18 Hybrid cardiac imaging using PET/MRI: a joint position state… (10.1186/s41824-018-0032-4)
Abstract ORCID
42.25 6
19 Assessment of a novel 32-channel phased array for cardiovasc… (10.1186/s41824-019-0061-7)
Abstract ORCID
42.25 6
20 The machine learning horizon in cardiac hybrid imaging (10.1186/s41824-018-0033-3)
Abstract
39.21 36
21 Prevalence and prognostic value of increased uptake in bone… (10.1186/s41824-017-0020-0)
Abstract ORCID
38.91 5
22 Positron emission tomography in breast cancer: 18F- FDG and… (10.1186/s41824-018-0039-x)
Abstract ORCID
38.91 5
23 [18F]FDG-PET/CT texture analysis in thyroid incidentalomas:… (10.1186/s41824-017-0009-8)
Abstract
36.56 28
24 Hybrid FDG-PET/MR imaging of chronic osteomyelitis: a prospe… (10.1186/s41824-019-0055-5)
Abstract
34.04 22
25 Glucose-level dependent brain hypometabolism in type 2 diabe… (10.1186/s41824-021-00097-z)
ORCID
34.04 22
26 Ability of artificial intelligence to diagnose coronary arte… (10.1186/s41824-019-0052-8)
Abstract
32.53 19
27 ROC study and SUV threshold using quantitative multi-modal S… (10.1186/s41824-019-0057-3)
Abstract
32.53 19
28 An artefact of PET attenuation correction caused by iron ove… (10.1186/s41824-017-0015-x)
Abstract ORCID
30.10 3
29 Multiparametric 18F–FDG PET/MR follow-up in a patient with a… (10.1186/s41824-017-0016-9)
Abstract ORCID
30.10 3
30 Simultaneous 13N-Ammonia and gadolinium first-pass myocardia… (10.1186/s41824-019-0062-6)
Abstract
30.10 15
31 The role of hybrid bone SPECT/CT imaging in the work-up of t… (10.1186/s41824-018-0026-2)
Abstract
28.65 13
32 Assessment of 18F-FDG uptake in idiopathic pulmonary fibrosi… (10.1186/s41824-018-0045-z)
Abstract
28.65 13
33 Ground glass pulmonary nodules: their significance in oncolo… (10.1186/s41824-017-0021-z)
Abstract
27.85 12
34 Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for dete… (10.1186/s41824-022-00127-4)
ORCID
26.98 11
35 Impact of metal implants on xSPECT/CT Bone reconstruction: t… (10.1186/s41824-020-00087-7)
ORCID
26.03 10
36 The prognostic value of preoperative FDG-PET/CT metabolic pa… (10.1186/s41824-018-0042-2)
Abstract
25.00 9
37 Radionuclide imaging of inflammation in atherosclerotic vasc… (10.1186/s41824-019-0053-7)
Abstract
25.00 9
38 Feasibility of simultaneous PET-MR perfusion using a novel c… (10.1186/s41824-017-0008-9)
Abstract
23.86 8
39 Discrepancy between significant fibrosis and active inflamma… (10.1186/s41824-019-0056-4)
Abstract
23.86 8
40 Characterization of the left ventricular arrhythmogenic subs… (10.1186/s41824-019-0060-8)
Abstract ORCID
23.86 2
41 The effect of reduced scan time on response assessment FDG-P… (10.1186/s41824-021-00096-0)
ORCID
23.86 8
42 A new member in the EJNMMI family: the European Journal of H… (10.1186/s41824-017-0010-2)
Abstract References ORCID
22.58 1
43 European Journal of Hybrid Imaging: the journey continues (10.1186/s41824-018-0049-8)
Abstract References ORCID
22.58 1
44 Comparative analysis of two timepoints on [18F]FAPI-42 PET/C… (10.1186/s41824-023-00186-1)
ORCID
22.58 7
45 Diagnostic performance of hybrid cardiac SPECT/CT imaging fo… (10.1186/s41824-017-0023-x)
Abstract
21.13 6
46 Pre-treatment 18F-choline PET/CT is prognostic for biochemic… (10.1186/s41824-018-0034-2)
Abstract
21.13 6
47 18F-DCFPyL PET/CT in primary staging of prostate cancer (10.1186/s41824-018-0044-0)
Abstract
21.13 6
48 Evaluation of 511 keV photon attenuation by a novel 32-chann… (10.1186/s41824-020-00076-w)
ORCID
21.13 6
49 Prevalence of incidental thyroid malignancy on routine 18F-f… (10.1186/s41824-020-00089-5)
ORCID
21.13 6
50 Added value of 18F-FDG PET-CT in staging of Ewing sarcoma in… (10.1186/s41824-018-0031-5)
Abstract
19.45 5